Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by vestor111on Jul 08, 2020 7:57am
114 Views
Post# 31237945

RE:RE:RE:RE:Retry on Why I keep buying.

RE:RE:RE:RE:Retry on Why I keep buying.Options are candy to these operations bacause they usually aren't pay well in a start-up/small cap.
I glaze on it a bit - figuring when the execute (if they can execute), it is money in the bank for the company.  

Hell when I was CEO, I got hundreds of thousands of share options.  Poof!  :-) 

Eye on the prize - Rutherrin is one of the most elegant cancer therapies one could consider - deadly food for cancer that stimulates immunity.  A fast, universal a solution to cancer - across virtually every cancer as one could concoct.  Because it is food.

Plants crave Brawndo!  :-) 

The big problem is the slow grind of the process...compound by the scamdemic shut down.  (The testing data is exposing the mortality rate to be less than a bad seasonal flu year. Scamdemic.)
<< Previous
Bullboard Posts
Next >>